Jefferies Starts Liquidia Technologies (LQDA) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Needham & Company Starts Liquidia Technologies (LQDA) at Buy
August 20, 2018 6:57 AM EDTNeedham & Company analyst Serge Belanger initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Buy rating and a price target of $30.00.
Belanger commented, "We initiate coverage of Liquidia Technologies (LQDA), a late-stage biopharma developing LIQ861, a differentiated inhaled PAH treatment based on its... More
Cowen Starts Liquidia Technologies (LQDA) at Outperform
August 20, 2018 5:40 AM EDTCowen analyst Ken Cacciatore initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Outperform rating and a price target of $40.00.
The analyst comments "The lead asset is LIQ861 for PAH, an inhaled reformulation of a known active molecule, treprostinil, that is more optimally... More
